Progyny (PGNY) Director Kevin K. Gordon Exercises Options, Sells Shares

What Happened Kevin K. Gordon, a director of Progyny, exercised 22,000 options on Sept. 10, 2026 at $13.00 per share (cost $286,000). All 22,000 shares from the exercise were disposed: 10,500 shares were withheld/used to satisfy tax obligations (reported at a weighted average price of $27.24, proceeds $286,020) and 11,500 shares were sold in the open market at a weighted average price of $27.12 (proceeds $311,858). Total proceeds reported from the dispositions equal about $597,878. The filing is an amended Form 4 correcting a clerical error in the reported weighted-average sale price.

Key Details

• Transaction date: 2026-09-10 (Form filed/Amended: 2026-09-18; accession 0001551306-26-000154)
• Option exercise: 22,000 shares @ $13.00 (acquisition cost $286,000)
• Tax withholding (F): 10,500 shares @ weighted avg $27.24 = $286,020
• Open-market sale (S): 11,500 shares @ weighted avg $27.12 = $311,858
• Net effect: 22,000 shares acquired by exercise and 22,000 shares disposed — effectively no net new shares retained from this exercise
• Footnotes: sale price reported as a weighted average across trades ($26.99–$27.24); amended filing corrected the previously misreported weighted average (from $27.9442 to $27.1181); the shares were fully vested
• Shares owned after transaction: not specified in the filing

Context This was a common cashless/partial-cash exercise pattern: options were exercised and the resulting shares were used to cover taxes and to sell in the open market. Such transactions typically reflect option exercise and routine tax/liquidity management rather than a clear buy/sell signal about the director’s view of the company. The amended filing corrects only a clerical pricing error; all other reported details remain unchanged.